Cargando…
The Junctophilin-2 Mutation p.(Thr161Lys) Is Associated with Hypertrophic Cardiomyopathy Using Patient-Specific iPS Cardiomyocytes and Demonstrates Prolonged Action Potential and Increased Arrhythmogenicity
Hypertrophic cardiomyopathy (HCM) is one of the most common genetic cardiac diseases; it is primarily caused by mutations in sarcomeric genes. However, HCM is also associated with mutations in non-sarcomeric proteins and a Finnish founder mutation for HCM in non-sarcomeric protein junctophilin-2 (JP...
Autores principales: | Valtonen, Joona, Prajapati, Chandra, Cherian, Reeja Maria, Vanninen, Sari, Ojala, Marisa, Leivo, Krista, Heliö, Tiina, Koskenvuo, Juha, Aalto-Setälä, Katriina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10295168/ https://www.ncbi.nlm.nih.gov/pubmed/37371654 http://dx.doi.org/10.3390/biomedicines11061558 |
Ejemplares similares
-
Heterozygous junctophilin-2 (JPH2) p.(Thr161Lys) is a monogenic cause for HCM with heart failure
por: Vanninen, Sari U. M., et al.
Publicado: (2018) -
HiPSC-derived cardiomyocyte to model Brugada syndrome: both asymptomatic and symptomatic mutation carriers reveal increased arrhythmogenicity
por: Penttinen, Kirsi, et al.
Publicado: (2023) -
DSP p.(Thr2104Glnfs*12) variant presents variably with early onset severe arrhythmias and left ventricular cardiomyopathy
por: Heliö, Krista, et al.
Publicado: (2020) -
Divergent effects of adrenaline in human induced pluripotent stem cell-derived cardiomyocytes obtained from hypertrophic cardiomyopathy
por: Prajapati, Chandra, et al.
Publicado: (2018) -
Fluorescent hiPSC-derived MYH6-mScarlet cardiomyocytes for real-time tracking, imaging, and cardiotoxicity assays
por: Maria Cherian, Reeja, et al.
Publicado: (2022)